News & Events

Dec 19, 2013

ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors

Read More

Dec 02, 2013

ViaCyte to Present at the 25th Piper Jaffray Healthcare Conference

Read More

Oct 29, 2013

ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine

Read More

Oct 16, 2013

ViaCyte to Present at the JDRF 8th Annual T1D Global Path to a Cure Symposium

Read More

Oct 10, 2013

Viacyte to Present Update On VC-01™ Combination Product Development at 2013 Stem Cell Meeting on The Mesa

Read More

Jul 10, 2013

ViaCyte, Inc. raises $10.6 Million in a Private Financing to Support Clinical Development of its Cell Therapy Product for Insulin Dependent Diabetes

Read More

Jul 03, 2013

Viacyte Inc. selected as one of 2013’s “Cool Companies”

Read More

Feb 13, 2013

JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte

Read More

Jan 31, 2013

ViaCyte’s Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012

Read More